TY  - CONF

T1  - Cost-Effectiveness of Ceritinib In Previously Untreated ALK-Positive Non-Small Cell Lung Cancer in the United Kingdom

JO  - Value in Health

PY  - 2018/05/01

AU  - Xie J

AU  - Knoll S

AU  - Slowley A

AU  - Bensimon A

AU  - Vieira J

AU  - Chilcott J

AU  - Paisley S

AU  - Zhou Z

ED  - 

DO  - DOI: 10.1016/j.jval.2018.04.182

PB  - Elsevier BV

VL  - 21

SP  - S29

EP  - S29

Y2  - 2024/12/22

ER  -